Coronavirus epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Region) |
(→Region) |
||
| Line 41: | Line 41: | ||
* The majority of the cases of MERS-CoV infection were reported in the Middle East (mainly in the Kingdom of Saudi Arabia) before spreading to 27 other countries. | * The majority of the cases of MERS-CoV infection were reported in the Middle East (mainly in the Kingdom of Saudi Arabia) before spreading to 27 other countries. | ||
* The majority of the cases of 2019-nCoV infection has been reported in China and it has spread to 26 countries (including the United States) so far.<ref>{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html|title=|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | * The majority of the cases of 2019-nCoV infection has been reported in China and it has spread to 26 countries (including the United States) so far.<ref>{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html|title=|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | ||
**For more real-time details regarding the spread of 2019-nCoV | **For more real-time details regarding the spread of 2019-nCoV, click [https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 here]. | ||
==Recent Outbreaks== | ==Recent Outbreaks== | ||
| Line 77: | Line 77: | ||
|} | |} | ||
* | |||
* | |||
==References== | ==References== | ||
Revision as of 23:07, 31 January 2020
|
Coronavirus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coronavirus epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Coronavirus epidemiology and demographics |
|
Risk calculators and risk factors for Coronavirus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Due to the lack of data, the exact incidence rate of coronavirus infections can not be approximated. From June 2012 to April 2018, MERS-CoV infection was prevalent in 2206 people globally.
Epidemiology and Demographics
Incidence
- Due to the lack of data, the exact incidence rate of coronavirus infections can not be approximated.
Prevalance
- From June 2012 to April 2018, MERS-CoV infection was prevalent in 2206 people globally.
Case-fatality rate
- With 8,098 confirmed cases, the case fatality-rate of SARS was 9.6%.[1]
- With 2465 laboratory-confirmed cases, the case fatality-rate of MERS was 34.4%.
- The case fatality-rate of 2019-nCoV has not yet been established.
Age
- Patients of all age groups can develop the disease.
Race
- Coronavirus infections affect all races.
Gender
- Coronavirus infections affect men and women equally.
Region
- The majority of the cases of SARS-CoV infection were reported in China before spreading to 29 other countries.[2]
- The majority of the cases of MERS-CoV infection were reported in the Middle East (mainly in the Kingdom of Saudi Arabia) before spreading to 27 other countries.
- The majority of the cases of 2019-nCoV infection has been reported in China and it has spread to 26 countries (including the United States) so far.[3]
- For more real-time details regarding the spread of 2019-nCoV, click here.
Recent Outbreaks
2019-nCoV
Global
- An outbreak of pneumonia of unknown etiology in Wuhan City was initially reported to WHO on December 31, 2019. Chinese health authorities have confirmed more than 40 infections with a novel coronavirus as the cause of the outbreak. Reportedly, most patients had epidemiological links to a large seafood and animal market. The market was closed on January 1, 2020. Currently, Chinese health authorities report no community spread of this virus, and no transmission among healthcare personnel caring for outbreak patients. No additional cases of infection with 2019-nCoV have been identified in China since January 3, 2020.
- On January 13, 2020 public health officials in Thailand confirmed detection of a human infection with 2019-nCoV in a traveler from Wuhan, China. This was the first confirmed case of 2019-nCoV documented outside China. On January 17, 2020 a second case was confirmed in Thailand, also in a returned traveler from Wuhan City. On January 15, 2020 health officials in Japan confirmed 2019-nCoV infection in a returned traveler from Wuhan City. These persons had onset dates after January 3, 2020. These cases did not report visiting the large seafood and animal market to which many cases in China have been linked.
- On January 11, 2020, CDC updated the level 1 travel health notice (“practice usual precautions”) for Wuhan City, Hubei Province, China with additional information (originally issued on January 6, 2020)
USA
Patients Under Investigation (PUI) in the United States*†
As of 1/31/2020
| Positive | 6 |
|---|---|
| Negative | 114 |
| Pending | 121 |
| Total | 241 |
References
- ↑ Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (January 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China". Int. J. Infect. Dis. 91: 264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.
- ↑ Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (January 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China". Int. J. Infect. Dis. 91: 264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.
- ↑ https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html. Missing or empty
|title=(help)